Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study
Titel:
Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study
Auteur:
Ortega, Vanesa Antón, Antonio Garau, Isabel Afonso, Noemia Calvo, Lourdes Fernández, Yolanda Martínez-García, María Blanco, Esperanza Zamora, Pilar García, Mirta Illarramendi, José Juan Rodríguez Sánchez, César Augusto Sampayo, Miguel Aguirre, Elena Pérez-García, José Manuel Cortés, Javier Llombart-Cussac, Antonio